Dolby Laboratories (DLB) EBT Margin (2009 - 2026)

Dolby Laboratories has reported EBT Margin for 18 years, with the latest figure at 30.26% in Q1 2026.

• For the quarter ending Q1 2026, EBT Margin fell 228.0% year-over-year to 30.26%; the trailing twelve-month figure through Mar 2026 stood at 21.14% (down 282.0% YoY), and the FY2025 full-year result was 22.49%, down 204.0% from the prior year.
• EBT Margin for Q1 2026 stood at 30.26%, up from 20.65% in the prior quarter.
• The five-year high for EBT Margin was 33.4% in Q1 2024, with the low at 3.11% in Q3 2023.
• Historically, EBT Margin has averaged 20.47% across 5 years, with a median of 19.6% in 2024.
• Annual changes were most pronounced in 2022 — EBT Margin sank 1372 bps — and 2023, when it jumped 1821 bps.
• Dolby Laboratories' EBT Margin stood at 29.85% in 2022, then decreased by 14 bps to 25.61% in 2023, then declined by 6 bps to 24.1% in 2024, then slipped by 14 bps to 20.65% in 2025, then jumped by 46 bps to 30.26% in 2026.
• The last three EBT Margin figures came in at 30.26% (Q1 2026), 20.65% (Q4 2025), and 13.57% (Q3 2025), per Business Quant data.